Cardiovascular Risk Management and Hepatitis C: Combining Drugs

Direct-acting antivirals (DAAs) are known victims (substrate) and perpetrators (cause) of drug–drug interactions (DDIs). These DAAs are used for the treatment of hepatitis C virus (HCV) infections and are highly effective drugs. Drugs used for cardiovascular risk management are frequently used by HC...

Descripción completa

Detalles Bibliográficos
Autores principales: Smolders, Elise J., ter Horst, Peter J. G., Wolters, Sharon, Burger, David M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2018
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6451722/
https://www.ncbi.nlm.nih.gov/pubmed/30259390
http://dx.doi.org/10.1007/s40262-018-0710-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6451722/
https://www.ncbi.nlm.nih.gov/pubmed/30259390
http://dx.doi.org/10.1007/s40262-018-0710-1

Ejemplares similares